1 Min Read
Feb 7 (Reuters) - Taro Pharmaceutical Industries Ltd :
* EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.